Skip to main content

Table 2 Univariate survival analysis (log-rank tests) of patient-related, tumor-related and therapy-related parameters

From: Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

Parameter

Distant metastasis-free survival

P

Disease-free survival

P

Overall survival

P

Actuarial 5-year data (standard deviation)

49 (± 9)

 

50 (± 10)

 

59 (± 9)

 

Age

      

   <50 years

37 (± 15)

 

43 (± 14)

 

38 (± 16)

 

   >50 years

52 (± 12)

0.09

51 (± 12)

0.09

69 (± 10)

0.06

T stage

      

   T1/T2

66 (± 9)

 

68 (± 8)

 

75 (± 9)

 

   T3/T4

16 (± 13)

0.001

16 (± 13)

0.003

26 (± 15)

0.01

Differentiation/grade

      

   Moderate/G2

54 (± 12)

 

58 (± 11)

 

49 (± 15)

 

   Poor/G3

42 (± 15)

0.40

42 (± 15)

0.52

67 (± 12)

0.84

Number of positive lymph nodes

      

   1–3

64 (± 20)

 

60 (± 21)

 

80 (± 15)

 

   ≥4

41 (± 10)

0.005

43 (± 10)

0.004

50 (± 11)

0.03

Estrogen receptor

      

   Positive

57 (± 14)

 

58 (± 14)

 

63 (± 13)

 

   Negative

37 (± 12)

0.04

36 (± 12)

0.03

52 (± 13)

0.14

Progesterone receptors

      

   Positive

47 (± 20)

 

50 (± 21)

 

56 (± 16)

 

   Negative

46 (± 10)

0.22

46 (± 11)

0.21

60 (± 12)

0.83

hif-1α expression

      

   Intense

38 (± 15)

 

38 (± 15)

 

53 (± 17)

 

   Moderate

48 (± 14)

 

50 (± 13)

 

50 (± 22)

 

   No

56 (± 16)

0.12

58 (± 16)

0.13

66 (± 13)

0.46

hif-1α expression

      

   Yes

43 (± 10)

 

44 (± 10)

 

55 (± 13)

 

   No

56 (± 16)

0.04

58 (± 16)

0.04

66 (± 13)

0.21

  1. hif-1α, hypoxia-inducible factor 1 alpha.